Intracervical Vasopressin — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Intracervical Vasopressin — Stella

Recruiting

Back to Retained Products of Conception trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

The OB/GYN Center, Greenville, South Carolina

Key details

Phase

Post-approval study

Sponsor

Prisma Health-Upstate

Enrollment target

~50 participants

Started

October 2025

Primary completion

August 2026

Age range

18 Years – 51 Years

Sex

Female only

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov